Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis

Launched by DR. SOETOMO GENERAL HOSPITAL · Aug 11, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female aged ≥18 years
• • AD patients who meet the criteria for AD diagnosis according to the Hanifin-Rajka criteria.
• • Patients with mild-moderate AD according to the SCORAD index.
• • Patients who have AD lesions on the hands and/or feet.
• • Patients with good general condition.
• • Patients are willing to participate in the study and sign the informed consent.
• Exclusion Criteria:
• • Pregnant and lactating patients.
• • Patients with a history of allergies to ingredients contained in moisturizers
• • Patients who clinically have other skin diseases such as psoriasis, seborrheic dermatitis, contact dermatitis or AD with secondary infections that can affect the SCORAD index parameters, skin hydration, skin pH and side effects on the skin area being assessed.
• • Patients receiving topical or systemic immunomodulatory and/or immunosuppressant therapy.
• • Patients receiving topical and/or systemic antibiotic therapy
• • Patients receiving systemic antihistamine therapy (patients who require antihistamines during the study will be recorded on the observation sheet)